First, when analyzing the osteoprotegerin (OPG), RANK, and the RANK-Ligand (RANKL) system, the OPG levels were significantly higher in patients with PAD than they were in patients without PAD [20]. This evidence concerns the gene TNFSF11 and peripheral arterial disease.